Electrophoretic Separations
Scientists used quantitative analysis to trial anti-cancer agent
Aug 01 2011
In a study published by BMC Cancer, Chinese scientists investigated whether 5-allyl-7-gen-difluoromethoxychrysin (AFMC) could inhibit proliferation in various cancer cell lines and promote tumour necrosis.
In a method involving flow cytometry, propidium iodide fluorescence staining and agarose gel electrophoresis, the scientists found that subtoxic concentrations of AFMC make human non-small cell lung cancer (NSCLC) A549 cells more sensitive to tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apoptosis.
Additionally, the study found that treating A549 cells with AFMC considerably provoked the expression of death receptor 5 (DR5), while also increasing the proliferation of Sub-G1 cells.
However, AFMC-mediated induction of DR5 expression was not observed in human embryo lung WI-38 cells, and AFMC did not makeWI-38 cells more sensitive to TRAIL-induced apoptosis.
The team suggested that AFMC "synergistically enhances TRAIL-mediated apoptosis in NSCLC cells" by increasing the amounts of DR5.
Digital Edition
Chromatography Today - Buyers' Guide 2022
October 2023
In This Edition Modern & Practical Applications - Accelerating ADC Development with Mass Spectrometry - Implementing High-Resolution Ion Mobility into Peptide Mapping Workflows Chromatogr...
View all digital editions
Events
Jul 07 2024 Dublin, Ireland
Jul 20 2024 Denver, CO, USA
Jul 21 2024 Cape Town, South Africa
ACS National Meeting - Fall 2024
Aug 18 2024 Denver, CO, USA
Sep 04 2024 Chiba, Tokyo, Japan